Relative Strength Alert For Raptor Pharmaceuticals

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Friday, shares of Raptor Pharmaceuticals Corp. ( RPTP) entered into oversold territory, hitting an RSI reading of 25.8, after changing hands as low as $11.70 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 50.9. A bullish investor could look at RPTP's 25.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of RPTP shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Raptor Pharmaceuticals Corp. 1 Year Performance Chart

Looking at the chart above, RPTP's low point in its 52 week range is $5.40 per share, with $17.72 as the 52 week high point — that compares with a last trade of $11.75.

According to the ETF Finder at ETF Channel, RPTP makes up 1.04% of the SPDR S&P Biotech ETF ( XBI) which is trading up by about 0.9% on the day Friday.

If you liked this article you might like

Drug Win for Depomed Could Be Hurdle for Starboard

Arbor and Purdue Seen as Likely Bidders for DepoMed

More Rare Disease Dealmaking to Follow Horizon's Raptor Deal

Fed Dove Brainard Pushes Stocks Into Rally Mode

Closing Bell: Fed's Brainard Cautions 'Prudence'; U.S. Stocks Soar